Safety and Efficacy Data
In clinical trials, the IMT procedure improved visual acuity and quality of life in the majority of subjects with Late-Stage Age-Related Macular Degeneration (AMD).
Bring Hope Back to Patients with Late-Stage Age-Related Macular Degeneration (AMD)
Late-stage age-related macular degeneration (AMD) is the most advanced form of AMD, the leading cause of legal blindness in the U.S. and Europe (1,2) Currently there is no known treatment that can cure for late-stage AMD (bilateral geographic atrophy or disciform scars on both eyes).
Central vision loss resulting from late-stage AMD cannot be corrected with glasses, contact lenses, anti-VEGF injections, or surgically implanted intraocular lenses (IOLs). (1) Individuals with this level of bilateral vision loss may use external appliances such as hand-held magnifying eyeglasses or a head-mounted telescope in order to enlarge images onto the retina. There are other assistive devices that increase illumination to enhance visual acuity. However, these devices have inherent limitations known to ophthalmologists and other eye care specialists (e.g., limited field of view, disruption of image stability; vestibular-ocular reflex issues with head motion; poor compliance and utilization; and limited utility in dynamic ‘on-the-go’ or social situations).
SING IMT™ Mechanism of Action
With a CE-mark in the EU, the SING-IMTTM is indicated for patients with late-stage AMD. Although the SING IMT does not completely reverse all vision loss due to AMD, it has been shown to significantly improve both central visual acuity and quality of life, which can make a profound and meaningful impact on your patient’s interaction with their world around them. (1,3) The micro-optical telescope is implanted in one eye to magnify objects onto healthy photoreceptors in areas surrounding the macula. This increases the image size and resolution afforded to the perimacular retina. The telescope-implanted eye is then used for central vision; the non-implanted eye is used for peripheral vision. A multidisciplinary team led by a retina specialist provides patient identification, candidacy assessment, follow-up, and visual training/rehabilitation.
Learn more about our novel IMT technologyAbout the SING IMT Technology
The SING IMT is based on Galilean design, featuring ultra-precision, wide-angle micro-optics that work in conjunction with the cornea to magnify objects in view, allowing patients to see naturally in a variety of environments.
Learn more
Behind the Lens of Telescope Implants
The SING IMT is housed in a prosthetic device composed of three primary components: a glass capsule that contains wide-angle micro-optical elements; a clear polymethylmethacrylate (PMMA) carrier; and a blue PMMA light restrictor. The sealed optical component is snap-fitted into the carrier plate.
About Implantable Telescope Components